A carregar...
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy
We recently reported that BRAF V600E is the principal oncogenic driver of papillary craniopharyngioma, a highly morbid intracranial tumor commonly refractory to treatment. Here, we describe our treatment of a man age 39 years with multiply recurrent BRAF V600E craniopharyngioma using dabrafenib (150...
Na minha lista:
Publicado no: | J Natl Cancer Inst |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Oxford University Press
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4862417/ https://ncbi.nlm.nih.gov/pubmed/26498373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv310 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|